Keyphrases
Bacteremia
100%
Treatment Outcome
100%
Carbapenems
100%
Klebsiella Pneumoniae Carbapenemase
100%
Combination Therapy
100%
Klebsiella Pneumoniae Bacteremia
100%
Adjusted Odds Ratio
60%
30-day Mortality
60%
Minimum Inhibitory Concentration
40%
Meropenem
40%
Monotherapy
40%
Carbapenem-sparing
40%
Clinical Outcomes
20%
Logistic Regression Analysis
20%
Outcome Prediction
20%
Multiplex
20%
Optimal Treatment
20%
Therapeutic Strategies
20%
Medical Center
20%
Mortality Prediction
20%
Monomicrobial
20%
Imipenem
20%
Polymerase Complex
20%
Crude Mortality
20%
Ertapenem
20%
Active Agent
20%
Improved Survival
20%
Combination Regimen
20%
Ther
20%
Patients With Critical Illnesses
20%
Therapeutic Effectiveness
20%
Clinical Prognostic Factors
20%
Carbapenemase Genes
20%
Medicine and Dentistry
Klebsiella pneumoniae
100%
Bloodstream Infection
100%
Combination Therapy
100%
Carbapenem
100%
Mortality Rate
33%
Odds Ratio
33%
Meropenem
22%
Monotherapy
22%
Beta-Lactamase
22%
Carbapenemase
22%
Infection
11%
Retrospective Study
11%
Pathogen
11%
Multivariate Logistic Regression Analysis
11%
Critical Illness
11%
Prognostic Factor
11%
Imipenem
11%
Ertapenem
11%
Carbapenem Derivative
11%
Polymerase
11%
Salicylate Sodium
11%
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
100%
Combination Therapy
100%
Klebsiella pneumoniae
100%
Carbapenem
100%
Mortality Rate
33%
Minimum Inhibitory Concentration
22%
Meropenem
22%
Monotherapy
22%
Carbapenemase
22%
Infection
11%
Infectious Agent
11%
Retrospective Study
11%
Imipenem
11%
Ertapenem
11%
Critical Illness
11%
Carbapenem Derivative
11%
Salicylate Sodium
11%